Herbal medicine for epilepsy seizures in Asia, Africa and Latin America: A systematic review

Abstract Relevance More than 70 million people suffer epilepsy worldwide. Low availability of anti-epileptic drugs, side-effects and drug-resistant epilepsy affect the quality of life of persons with epilepsy in countries with a poorly developed health system. Herbal medicine is frequently used for this neurological condition. Objectives The main objective was to provide a detailed analysis of Herbal Medicine used for neurological conditions related with epilepsy in Asia, Africa and Latin America. More broadly, this study aims to highlight species with assessed efficacy (cross-cultural use, pharmacologicaleffects on models of epileptic seizures) and safety (toxicological data in laboratory) information, in order to point out species of interest for further studies. A critical assessment of models used in pharmacologicalevaluations was done. Materials and methods The systematic search for Herbal Medicine treatments for epilepsy was performed considering all the articles published until February 2017 through three scientific databases. It was made with MeSH terms and free text defining the epilepsy seizures and plant species. We included studies carried out in Asia, Africa and Latin America. All articles reporting the use of Herbal Medicine to treat epilepsy seizures and/or their pharmacologicalevaluation were retained for further analysis. Results The search yielded 1886 articles, from 30 countries. Hundred and six articles published between 1982 and 2017 were included, corresponding to a total of 497 use reports for 351 plant species belonging to 106 families. Three hundred and seventy seven use reports corresponding to 264 species in ethnopharmacological surveys and 120 evaluation reports corresponding to 107 species were noted. Twenty-nine reports, for 29 species, combined both ethnopharmacological and pharmacologicalevaluation. Fifty eight studies originated from Africa, 35 studies from Asia and 18 from Latin America. Highest use report was noted for rhizomes of Acorus calamusL. (12 use report in 1 country) and leaves of Bacopa monnieri(L.) Wettst. (8 use report in 2 countries). Therefore these species display the highest use convergence. Regarding pharmacologicalevaluation most studied species were: Leonotis leonurus(L.) R.Br. (4 evaluation reports in 1 country), Uncaria rhynchophylla(Miq.) Miq. ex Havil. (3 evaluation reports in 2 countries) and Calotropis gigantea(L.) Dryand. (3 evaluation reports in 1 country). In vivo models of chronic epilepsy were more relevant than in vitro models or chemical models inducing acute seizures for pharmacologicalassessment. Conclusion Species with the highest use report were not those with pharmacologicalevaluation. It will be pertinent to assess the pharmacologicaleffects and safety of medicinal plants used mostly by traditional healers on predictive models of seizures.